Eagle Health Investments LP Alnylam Pharmaceuticals, Inc. Transaction History

Eagle Health Investments LP

$569 Million
Q2 2024

A detailed history of Eagle Health Investments LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Eagle Health Investments LP holds 76,256 shares of ALNY stock, worth $20.3 Million. This represents 3.25% of its overall portfolio holdings.

Number of Shares

76,256

Previous 48,356 57.7%

Holding current value

$20.3 Million

Previous $7.23 Million 156.44%

% of portfolio

3.25%

Previous 1.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $4 Million - $6.89 Million	27,900 Added 57.7%	76,256 $18.5 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $13 Million - $17.5 Million	-88,400 Reduced 64.64%	48,356 $7.23 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $3.46 Million - $4.47 Million	-18,960 Reduced 12.18%	136,756 $27.4 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $1.11 Million - $1.45 Million	-6,000 Reduced 3.71%	155,716 $37 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $1.71 Million - $2.86 Million	12,336 Added 8.26%	161,716 $32.4 Million
Q2 2022 Aug 11, 2022	BUY	$120.42 - $169.29 $2.18 Million - $3.07 Million	18,136 Added 13.82%	149,380 $21.8 Million
Q1 2022 May 12, 2022	BUY	$127.18 - $173.91 $2.23 Million - $3.05 Million	17,542 Added 15.43%	131,244 $21.4 Million
Q4 2021 Feb 10, 2022	BUY	$159.56 - $209.29 $3.77 Million - $4.94 Million	23,600 Added 26.19%	113,702 $19.3 Million
Q3 2021 Oct 20, 2021	SELL	$169.75 - $207.73 $3.07 Million - $3.76 Million	-18,077 Reduced 16.71%	90,102 $17 Million
Q1 2021 Apr 23, 2021	BUY	$126.83 - $175.69 $2.84 Million - $3.93 Million	22,386 Added 26.09%	108,179 $15.3 Million
Q4 2020 Feb 04, 2021	BUY	$122.97 - $147.0 $10.5 Million - $12.6 Million	85,793 New	85,793 $11.2 Million

Others Institutions Holding ALNY

# of Institutions

636

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.15M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.

Account

Eagle Health Investments LP Alnylam Pharmaceuticals, Inc. Transaction History